Skip to main content
. 2021 Oct 13;43(3):1592–1605. doi: 10.3390/cimb43030113

Figure 2.

Figure 2

Cell survival (%) using (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide) (MTT) method on HIEC-6 cells. A two-way ANOVA, using dose and treatment as factors, followed by Tukey-HSD was completed where differences were considered significant if p < 0.05. No significant differences between CH doses or treatments were observed.